Kimpod 50 Dry Syrup Orange contains Cefpodoxime Proxetil 50mg/5ml, a third-generation cephalosporin antibiotic indicated for the treatment of a variety of bacterial infections. It is effective against both gram-positive and gram-negative pathogens, making it suitable for respiratory tract infections, urinary tract infections, skin and soft tissue infections, and otitis media. The dry syrup formulation is designed for pediatric use, providing an accurate and palatable dosing option for children who have difficulty swallowing tablets. Cefpodoxime Proxetil acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death, thereby halting the progression of infection. The orange-flavored syrup enhances compliance in pediatric patients. Kimpod 50 should be administered as prescribed by a healthcare professional, with dosage adjusted according to the severity of infection and patient weight. It is important to complete the full course of therapy to prevent resistance development. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal pain. Hypersensitivity reactions are rare but require immediate medical attention. This medication is contraindicated in patients with known allergy to cephalosporins or penicillins. Use with caution in patients with renal impairment.